Investment Rating - The investment rating for the industry is "Positive" (首次) [8] Core Insights - The OpenClaw application continues to generate high demand for computing power, with significant interest from major cloud service providers in China [4][11] - The Seedance 2.0 model, launched by ByteDance, has entered the commercialization phase, which is expected to further drive the demand for computing power [5][12] - Domestic and international cloud service providers have raised prices, indicating strong downstream demand for computing resources [6][13] Summary by Sections Investment Opportunities - OpenClaw's popularity has led to a surge in computing power demand, with various cloud providers announcing support for the application [4][11] - Seedance 2.0's pricing structure has been established, with costs set at 28 RMB per million tokens for video input and 46 RMB per million tokens without video input, which is expected to increase computing demand [5][12] - Price increases from major cloud providers like AWS and Google Cloud validate the robust demand from downstream users [6][13] Market Review - The Shanghai and Shenzhen 300 Index fell by 1.07%, while the computer index dropped by 5.29% during the week of March 2 to March 6, 2026 [15] Investment Recommendations - The report suggests focusing on the AI infrastructure industry chain, recommending companies such as Deepin Technology and Haiguang Information, with beneficiaries including Borui Data, Dongfang Guoxin, and others [7][14]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The company reported a revenue of 32.557 billion yuan for 2025, representing a year-on-year increase of 17.88%, and a net profit attributable to shareholders of 2.454 billion yuan, up 22.38% year-on-year. The fourth quarter of 2025 saw a revenue of 10.221 billion yuan, with a year-on-year growth of 18.25% and a net profit of 666 million yuan, increasing by 11.34% year-on-year [5] - The company is actively expanding its AI capabilities and international presence, having established 16 overseas branches in countries like Germany and France, and secured global orders from major brands such as Volkswagen, BMW, and Mercedes-Benz [7] - The company has adjusted its earnings forecasts for 2026-2027 due to slight pressure on the overall vehicle market demand, projecting net profits of 2.914 billion yuan for 2026 and 3.504 billion yuan for 2027, with corresponding EPS of 4.88 yuan and 5.87 yuan [5] Financial Performance - In 2025, the cockpit business generated revenue of 20.585 billion yuan, a year-on-year increase of 12.92%, while the intelligent driving business revenue reached 9.7 billion yuan, up 32.63%. The gross margin for the year was 19.07%, slightly down from 19.88% in 2024 [6] - The company achieved overseas revenue of 2.41 billion yuan in 2025, marking a significant year-on-year growth of 41.12% [7] - The financial summary indicates projected revenues of 38.4 billion yuan for 2026, with a year-on-year growth rate of 17.9%, and a net profit of 2.914 billion yuan, reflecting an 18.8% increase [8] Business Development - The company is enhancing its product pipeline with new platforms for cockpit systems and intelligent driving solutions, including HUD and vehicle domain controllers, which are expected to drive future growth [7] - The introduction of innovative products such as the "Chuanxing Zhiyuan" low-speed unmanned vehicle brand and the AI Cube for robotics indicates the company's commitment to diversifying its business and entering new markets [7]

Investment Rating - The investment rating for the industry is "Positive" (首次) [8] Core Insights - The OpenClaw application continues to generate high demand for computing power, with significant interest from major cloud service providers in China [4][11] - The Seedance 2.0 model, launched by ByteDance, has entered the commercialization phase, which is expected to further drive the demand for computing power [5][12] - Domestic and international cloud service providers have raised prices, indicating strong downstream demand for computing resources [6][13] Summary by Sections Investment Opportunities - OpenClaw's popularity has led to a surge in computing power demand, with various cloud providers announcing support for the application [4][11] - Seedance 2.0's pricing structure has been established, with costs set at 28 RMB per million tokens for video input and 46 RMB per million tokens without video input, indicating a move towards commercialization [5][12] - Price increases from major cloud providers like AWS and Google Cloud reflect robust downstream demand [6][13] Market Review - The market review for the week of March 2 to March 6, 2026, shows a decline in the CSI 300 index by 1.07% and a drop in the computer index by 5.29% [15] Investment Recommendations - The report suggests focusing on the AI infrastructure supply chain, recommending companies such as Deepin Technology and Haiguang Information, with beneficiaries including Borui Data, Dongfang Guoxin, and others [7][14]

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The dual policy support from the Two Sessions creates a window for layout in the food and beverage sector. The food and beverage index fell by 2.5% from March 2 to March 6, ranking 12th among primary sub-industries, underperforming the CSI 300 by approximately 1.4 percentage points. The meat products (+1.1%), beer (+0.9%), and dairy products (+0.1%) sectors performed relatively well. The government work report for 2026 prioritizes expanding domestic demand and boosting consumption, implementing special actions to enhance consumption recovery. The dual policy framework of "demand-side boost + supply-side expansion" is expected to drive the recovery of the food and beverage industry significantly [3][10][11]. Summary by Sections Weekly Viewpoints - The food and beverage index underperformed the market, with a decline of 2.5% and ranking 12th out of 28 industries. The meat products, beer, and dairy sectors showed relative strength [10][11]. Supply Chain Data - The report indicates a recovery in consumer spending and service consumption, with government initiatives aimed at increasing disposable income and enhancing social security. This is expected to benefit essential consumption categories such as liquor, snacks, and the catering supply chain [3][10]. Recommendations - Recommended stocks include: - Guizhou Moutai: Focused on sustainable development amidst shifting demand [4]. - Shanxi Fenjiu: Expected to grow despite short-term demand pressures [4]. - Ximai Foods: Anticipated steady growth in the oatmeal sector [4]. - Weilong: Projected to maintain growth in the konjac product line [4]. - Ganyuan Foods: Expected to benefit from a turnaround in trends [4]. Market Performance - The food and beverage sector's performance was below the market average, with specific stocks like Zhongxin Niya, New Dairy, and Chongqing Beer showing gains, while others like Jiugui Liquor and Youyou Foods faced declines [11][12]. Upstream Data - Recent data shows a decline in some upstream raw material prices, with whole milk powder prices down by 4.9% year-on-year, and fresh milk prices down by 1.9% year-on-year [16][19].

北交所策略专题报告 2026 年 03 月 08 日 HALO 交易掘金北交所：新质生产力核心资产的稀缺性与重估机遇 ——北交所策略专题报告 北交所研究团队 诸海滨（分析师） zhuhaibin@kysec.cn 证书编号：S0790522080007 政策支持+HALO 交易升温，北交所新质生产力主阵地高稀缺价值凸显 HALO 是"重资产、低淘汰"的缩写。在 AI 冲击下，HALO 的核心是寻找难以 被 AI 颠覆、拥有高壁垒实体资产的赛道，本质上是市场对轻资产模式"护城河" 的重新审视，AI 同时正在将一些市场最具标志性的"资本轻"赢家转变为"资本密 集型"工业公司。从美国市场来看，"HALO 交易"主要集中在四大大核心板块， 分别为材料、能源、工业和公共事业。以 2025 年 1 月 2 日为基数计算累计收益 率，截至 2026 年 3 月 6 日标普 500 行业指数中"HALO 交易"四大行业累计收 益率分别高于信息技术行业 3.57pcts、14.28pcts、13.00pcts、5.65pcts。政策方面， "两会"期间，国家要重点打造六大新兴支柱产业、六大未来产业。六大新兴支 柱产业包括集成电 ...

Investment Rating - The investment rating for the retail industry is "Positive" (maintained) [1] Core Insights - The report highlights the strong performance of domestic brands during the 38 promotional event, with significant sales figures and consumer demand for effective skincare products [23][25] - The report emphasizes the importance of emotional consumption themes and recommends high-quality companies in high-growth sectors [6][30][31] Summary by Sections Retail and Social Services Market Review - The retail and social services indices reported declines of 3.91% and 3.63% respectively during the week of March 2 to March 6, 2026, ranking 25th and 23rd among 31 primary industries [5][15] - Year-to-date, the retail index has decreased by 6.82%, while the social services index has increased by 3.01% [12][15] Industry Dynamics - The 38 promotional event saw domestic brands excel, with significant sales figures reported from live streaming platforms [23][25] - Key brands such as Pechoin and Betainy led in product selection and sales performance during the promotional period [23][24] Investment Recommendations - Investment focus areas include: - Gold and jewelry brands with differentiated product offerings, recommending companies like Laopuhuangjin and Chaohongji [6][30] - Offline retail companies adapting to market changes, recommending Yonghui Supermarket and Aiyingshi [6][30] - Domestic beauty brands that emphasize emotional value and innovative ingredients, recommending Maogeping and Shangmei [6][31] - Medical aesthetics firms with differentiated products, recommending Meilitiantian and Aimeike [6][31] Company Performance Highlights - Shangmei Co. is projected to achieve revenues of 9.1-9.2 billion yuan, a year-on-year increase of 34.0%-35.4%, with net profits expected to reach 1.14-1.16 billion yuan, up 41.9%-44.4% [27][29] - Zhou Dafu reported a retail value increase of 17.8% year-on-year for FY2026Q3, driven by product structure optimization [32]

Group 1 - The ongoing conflict between the US and Iran is driving up international oil prices, with Brent crude reaching $92.69 per barrel, the highest since 2024, and predictions of prices potentially soaring to $150 per barrel due to disruptions in energy transport from Gulf countries [2][11][12] - The rise in oil prices is expected to significantly impact the chemical industry, as oil is a primary raw material for most chemical products, leading to increased prices for petrochemical products and a favorable environment for coal chemical products to gain market share [2][12][18] - The coal chemical sector is becoming increasingly attractive for investment as the cost advantages of coal-based products over oil-based products are highlighted, especially when oil prices exceed the breakeven points for coal-to-olefins and coal-to-methanol projects [16][18] Group 2 - The North Exchange chemical new materials sector experienced a decline of 1.81% in the week from March 2 to March 6, 2026, with only the professional technical services and chemical products sub-sectors showing gains [4][28][29] - Key stocks that performed well during this period included Keli Co., which saw a rise of 38.90%, and other companies like Kaida Catalysis and Ruihua Technology, which also reported positive growth [32][35] - The overall market sentiment is reflected in the North Exchange 50 index, which closed at 1427.35 points, down 7.14% for the week, indicating a broader market downturn affecting various sectors [27][30] Group 3 - The report highlights the structural changes in the global chemical industry, particularly in Europe, where a significant retreat is occurring due to rising energy costs and reduced investment, leading to a loss of production capacity and increased unemployment [23] - Major chemical companies are shifting their focus towards China and North America, indicating a strategic realignment in response to the challenges faced in Europe, with firms like BASF and Total Energy increasing their investments in the Chinese market [23][24] - The report suggests that the ongoing geopolitical tensions and rising energy prices are creating new investment opportunities in the global chemical sector, particularly for companies with a high degree of globalization [24]

Investment Rating - The investment rating for Hechang Polymer (920089.BJ) is "Outperform" (maintained) [2] Core Views - The company is expected to achieve a revenue of 1.988 billion yuan in 2025, representing a year-on-year growth of 23.23%, and a net profit attributable to the parent company of 165 million yuan, reflecting a year-on-year increase of 36.33% [2][3] - The growth is driven by the continuous demand increase in the automotive and home appliance sectors, alongside a reduction in raw material costs, which enhances the company's profitability [3] - The introduction of strategic investors aims to empower the company's high-end product development and facilitate its entry into advanced fields such as semiconductors, robotics, and drones, thereby creating a second growth curve [4] Financial Summary - Revenue and net profit projections for 2025-2027 are as follows: - 2025: Revenue of 1.988 billion yuan, net profit of 165 million yuan - 2026: Revenue of 2.330 billion yuan, net profit of 207 million yuan - 2027: Revenue of 2.691 billion yuan, net profit of 243 million yuan - Earnings per share (EPS) are projected to be 1.10 yuan in 2025, 1.37 yuan in 2026, and 1.62 yuan in 2027, with corresponding price-to-earnings (P/E) ratios of 18.4, 14.7, and 12.5 respectively [6][9]

Group 1 - The report emphasizes the development of six emerging pillar industries and six future industries, including integrated circuits, aerospace, biomedicine, low-altitude economy, new energy storage, and intelligent robotics [13][16] - The total market value of integrated circuit-related companies on the North Exchange is 81.57 billion yuan, with 19 companies listed [18] - The aerospace and low-altitude economy sectors have a total of 16 related companies, with a combined market value of 79.26 billion yuan [22] Group 2 - The biomedicine sector includes 27 companies with a total market value of 80.00 billion yuan, highlighting the performance of companies like Deyuan Pharmaceutical, which reported a net profit of 236.93 million yuan, a year-on-year increase of 33.87% [28][30][32] - The new energy storage sector consists of 22 companies with a total market value of 105.24 billion yuan, featuring companies like Better Ray, which specializes in lithium battery anode materials [35][36] - The intelligent robotics sector comprises 22 companies with a total market value of 71.25 billion yuan, showcasing companies like Dingzhi Technology, which focuses on servo motors and related products [39]

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Insights - The clinical research organization (CRO) sector is experiencing a significant recovery, with new orders and backlog orders showing rapid growth. Notable companies like Medpace and Yino Science have reported substantial increases in new orders and revenue [4][14] - The price of experimental monkeys, a key material for preclinical research, has surged, indicating strong demand in the domestic innovative drug industry. The price has risen to over 130,000 yuan per monkey, up from approximately 90,000 yuan in mid-2025 [5][15] - The report emphasizes the continued recommendation of the domestic preclinical CRO sector, anticipating further acceleration in order growth [5][14] Summary by Sections Section 1: Order Growth in Preclinical CRO - Medpace signed new orders worth approximately 1.6 billion yuan in 2025, a year-on-year increase of about 45%, with revenue also growing by 12% [14][15] - Yino Science reported new orders of 1.135 billion yuan, up 38.62% year-on-year, with a backlog of 1.248 billion yuan, reflecting a 28.23% increase [14][15] - The backlog for Aopumai's subsidiary, Pengli Biology, reached 252 million yuan, a 37.68% increase year-on-year [14][15] Section 2: Market Performance - In the first week of March 2026, the pharmaceutical and biological sector fell by 2.78%, underperforming the CSI 300 index by 1.71 percentage points, ranking 17th among 31 sub-industries [6][17] - The in vitro diagnostics sector showed the highest increase, while the medical research outsourcing sector experienced the largest decline, down 4.99% [20][21] Section 3: Recommendations - The report maintains a positive outlook on the innovative drug and its supply chain, including CXO and research services, as well as emerging industries like AI and brain-machine interfaces [7] - Monthly recommendations include companies such as WuXi AppTec, CSPC Pharmaceutical Group, and Innovent Biologics, while weekly recommendations feature Aopumai, Medpace, and others [7]